Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
08/22/2007 | EP1819719A2 Oligonucleotide probes |
08/22/2007 | EP1819365A2 Compositions and methods for inducing an immune response in a mammal and methods of avoiding an immune response to oligonucleotide agents such as short interfering rnas |
08/22/2007 | EP1819364A2 Immunomodulatory compositions, combinations and methods |
08/22/2007 | EP1819358A2 Antibodies against vascular endothelial growth factor receptor-1 |
08/22/2007 | EP1819226A2 Immunostimulatory combinations and methods |
08/22/2007 | EP1660654A4 Expression vector |
08/22/2007 | EP1641422A4 Interleukin-21 analogs |
08/22/2007 | EP1622638A4 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
08/22/2007 | EP1402024B1 Templated molecules and methods for using such molecules |
08/22/2007 | EP1124568B1 Polyspecific binding molecules and uses thereof |
08/22/2007 | EP1017846B1 Control of immune responses by modulating activity of glycosyltransferases |
08/22/2007 | EP0773950B1 Linked peptide nucleic acids |
08/22/2007 | CN1333081C Preparation method of human genome DNA specimen |
08/22/2007 | CN1333076C Pig muscle enolase ENO3 and its use as genetic marker of pig production trait |
08/22/2007 | CN1333074C Production of trans-4-hydroxy-L-proline |
08/22/2007 | CN1332972C Method and apparatus for concentration and purification of nucleic acid |
08/22/2007 | CN101023186A Polypeptides for inducing a protective immune response against staphylococcus aureus |
08/22/2007 | CN101023185A Biomarkers for monitoring inhibition of impdh pathway |
08/22/2007 | CN101023184A Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes |
08/22/2007 | CN101023181A Method for enhancing production of isoprenoid compounds |
08/22/2007 | CN101023094A Preparation of alkyl-substituted 2-deoxy-2-fluoro-d-ribofuranosyl pyrimidines and purines and their derivatives |
08/21/2007 | USRE39793 Compositions for sorting polynucleotides |
08/21/2007 | US7259295 genetic engineered plants, whose cells are transfected with recombinant nucleic acid molecules that code a polyketide synthases for the production of polyunsaturated fatty acids (PUFAs); trangenic plants |
08/21/2007 | US7259258 Methods of attaching biological compounds to solid supports using triazine |
08/21/2007 | US7259256 Primers designed on basis of the difference of sequences among staphylococcal enterotoxin subtypes |
08/21/2007 | US7259255 Expression vector comprising yarrowia regulatory sequences for use in expression of preferential heterologous nucleotide sequences |
08/21/2007 | US7259254 Isolated, hybrid nucleic acids capable of binding to ligand; transcription activation |
08/21/2007 | US7259253 Comprises nucleotide sequences coding protein-608 and/or adlican-2 polypeptides for diagnosis, prevention and treatment of osteoporosis and/or bone disorders |
08/21/2007 | US7259252 Colorimetric analysis |
08/21/2007 | US7259251 Purified polynucleotide; cancer screening |
08/21/2007 | US7259244 Human homologue of the DBF4/ASK1 protein, nucleic acids, and methods related to the same |
08/21/2007 | US7259240 Primate prokineticin receptor polypeptides |
08/21/2007 | US7259235 Method for generating an immune response and reagents therefor |
08/21/2007 | US7259150 Oligonucleotides; nucleic acid; therapy, diagnosis; cardiovascular disorders, atherosclerosis, anticholesterol agents |
08/21/2007 | US7259014 Fusion protein delivery system and uses thereof |
08/21/2007 | US7259009 Self-rearranging DNA vectors |
08/21/2007 | US7259003 Genetically engineered microorganism for fermentaion of phenylalanine and threonine |
08/21/2007 | US7259002 Polynucleotide encoding a novel acyl coenzyme A, monoacylglycerol acyltransferase-3 (MGAT3), and uses thereof |
08/21/2007 | US7259000 Polynucleotides encoding chimeric chemokine receptors |
08/21/2007 | US7258983 Cardiotrophin-1 compositions and methods for the treatment of tumor |
08/21/2007 | US7258982 Using preferential regional hybridization of nucleotide sequence probes to genotype hepatitis viral serotypes |
08/21/2007 | US7258981 Sensitive proteasome sensor constructs and methods for their design and use |
08/21/2007 | US7258980 Determining non-nucleic acid molecule binding to target by competition with nucleic acid ligands |
08/21/2007 | US7258979 Method for monitoring the temperature of a biochemical reaction |
08/21/2007 | US7258978 Electrochemical method to measure DNA attachment to an electrode surface in the presence of molecular oxygen |
08/21/2007 | US7258977 Process for typing of HCV isolates |
08/21/2007 | US7258976 Method of preparing cell lysate |
08/21/2007 | US7258975 Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection |
08/21/2007 | US7258860 Compositions and methods for the therapy and diagnosis of lung cancer |
08/21/2007 | US7258855 Culturing a transformant in a medium, allowing the polypeptide having phospholipase a2 activity fo form and accumulating in the culture, recovering the polypeptide thus formed |
08/21/2007 | CA2475018C Novel processes for amplifying nucleic acid, post-termination labeling process for nucleic acid sequencing and producing nucleic acid having decreased thermodynamic stability |
08/16/2007 | WO2007031091A3 Rna antagonist compounds for the modulation of p21 ras expression |
08/16/2007 | WO2007025229A3 Compositions and their uses directed to hsp27 |
08/16/2007 | WO2006130525A3 Methods for immunotherapy of cancer |
08/16/2007 | WO2006038955A3 Novel therapeutic targets in cancer |
08/16/2007 | WO2006023766A3 P450 polynucleotides, polypeptides, and uses thereof |
08/16/2007 | WO2005113836A3 High through-put detection of pathogenic yeasts in the genus trichosporon |
08/16/2007 | WO2005106010A3 Methods for reducing or eliminating alpha-mannosidase resistant glycans in the production of glycoproteins |
08/16/2007 | WO2005051967A3 Oligonucleotides labeled with a plurality of fluorophores |
08/16/2007 | WO2005042717A3 Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods |
08/16/2007 | WO2004101810A3 Methods for the identification of protochlorophyllide oxidoreductase inhibitors |
08/16/2007 | WO2004060302A3 Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
08/16/2007 | WO2004053452A3 Assays relating to toll-like receptor activity |
08/16/2007 | WO2004000997A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
08/16/2007 | WO2003080856A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
08/16/2007 | WO2003022226A3 Neurotrophic components of the adnf i complex |
08/16/2007 | WO2002083916A8 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
08/16/2007 | WO2000026343A8 Tissue specific promoters and transgenic animals for the screening of pharmaceuticals |
08/16/2007 | US20070192908 Transcription Factor Stress-Related Proteins and Methods of Use in Plants |
08/16/2007 | US20070192907 Transgenic organisms with increased overall yield, increased yield of biomass or chemical components; genetic engineering; producing a plant tissue by growing a plant cell comprising an exogenous nucleic acid |
08/16/2007 | US20070192904 Flowering inhibition |
08/16/2007 | US20070192902 Genetic engineered plants; for seed-specific modification of fatty acid and protein in plant seeds |
08/16/2007 | US20070192901 Engineering single-gene-controlled staygreen potential into plants |
08/16/2007 | US20070192898 Proteins inducing multiple resistance of plants to phytopathogens and pests |
08/16/2007 | US20070192896 Transgenic corn seed with enhanced free lysine |
08/16/2007 | US20070192889 Nucleic acid molecules and other molecules associated with transcription in plants and uses thereof for plant improvement |
08/16/2007 | US20070192887 TAT-042 and methods of assessing and treating cancer |
08/16/2007 | US20070192886 TAT-044 and methods of assessing and treating cancer |
08/16/2007 | US20070192885 TAT-039 and methods of assessing and treating cancer |
08/16/2007 | US20070192884 TAT-038 and methods of assessing and treating cancer |
08/16/2007 | US20070192882 Hereditary angioedema type III |
08/16/2007 | US20070192880 Horming response element binding transregulators |
08/16/2007 | US20070191592 amidated peptide; stress-related conditions |
08/16/2007 | US20070191300 selectively modulating NF (Nuclear Factor)- kappa B dependent gene transcription in a cell comprised of modulating I kappa B kinase (IKK) alpha protein activity in the cell |
08/16/2007 | US20070191298 Beta Secretase Genes |
08/16/2007 | US20070191297 Methods of treating and monitoring systemic lupus erythematosus in individuals |
08/16/2007 | US20070191295 Gene silencing by systemic rna interference |
08/16/2007 | US20070191273 Modulation of angiogenesis |
08/16/2007 | US20070191270 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
08/16/2007 | US20070191268 Recombiant lubricin molecules and uses thereof |
08/16/2007 | US20070190621 Synthesis of oseltamivir carboxylates |
08/16/2007 | US20070190616 Using transglutaminase to form polymers from fusion peptides; enhances antigenicity; use in vaccines |
08/16/2007 | US20070190615 Use of a gene coding for the C4BP protein beta chain for producing recombinant dimeric proteins |
08/16/2007 | US20070190614 Methods and compositions for vitamin K epoxide reductase |
08/16/2007 | US20070190613 polypeptides that have been shown to be essential for Candida albicans growth and survival; Fungal Conserved Genes ("FCG"), or Conserved Unknown Reading Frames ("CURFs") |
08/16/2007 | US20070190612 31 Human Secreted Proteins |
08/16/2007 | US20070190611 Long-acting polypeptides and methods of producing same |
08/16/2007 | US20070190610 comprising at least two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to an EPO (erythropoietin) peptide ; improving a biological half life of an hGH polypeptide |
08/16/2007 | US20070190609 Expression vectors; transformed host cells; culturing the host cell to produce the encoded polypeptide; antiasthmatic agents; atopic allergy, and related disorders |
08/16/2007 | US20070190608 Thermostable alpha-amylases |